P21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear

Joseph Aslan, Asako Itakura, Kristina Haley, Garth W. Tormoen, Cassandra P. Loren, Sandra M. Baker, Jiaqing Pang, Jonathan Chernoff, Owen McCarty

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective-Rho GTPase proteins play a central role in regulating the dynamics of the platelet actin cytoskeleton. Yet, little is known regarding how Rho GTPase activation coordinates platelet activation and function. In this study, we aimed to characterize the role of the Rho GTPase effector, p21 activated kinase (PAK), in platelet activation, lamellipodia formation, and aggregate formation under shear. Approach and Results-Stimulation of platelets with the glycoprotein receptor VI agonist, collagen-related peptide, rapidly activated PAK in a time course preceding phosphorylation of PAK substrates, LIM domain kinase LIMK1 and the MAPK/ERK kinase MEK, and the subsequent activation of MAPKs and Akt. Pharmacological inhibitors of PAK blocked signaling events downstream of PAK and prevented platelet secretion as well as platelet aggregation in response to collagen-related peptide. PAK inhibitors also prevented PAK activation and platelet spreading on collagen surfaces. PAK was also required for the formation of platelet aggregates and to maintain aggregate stability under physiological shear flow conditions. Conclusions-These results suggest that PAK serves as an orchestrator of platelet functional responses after activation downstream of the platelet collagen receptor, glycoprotein receptor VI.

Original languageEnglish (US)
Pages (from-to)1544-1551
Number of pages8
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume33
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

p21-Activated Kinases
Pseudopodia
Platelet Aggregation
Glycoproteins
Platelet Activation
rho GTP-Binding Proteins
Blood Platelets
Lim Kinases
Collagen Receptors
Platelet Membrane Glycoproteins
MAP Kinase Kinase Kinases
Mitogen-Activated Protein Kinase Kinases
Actin Cytoskeleton
Collagen
Phosphorylation
Pharmacology

Keywords

  • Cell signaling
  • Platelet
  • Signal transduction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

P21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear. / Aslan, Joseph; Itakura, Asako; Haley, Kristina; Tormoen, Garth W.; Loren, Cassandra P.; Baker, Sandra M.; Pang, Jiaqing; Chernoff, Jonathan; McCarty, Owen.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, No. 7, 07.2013, p. 1544-1551.

Research output: Contribution to journalArticle

@article{fe92dc61099f489da227b4eb0857de90,
title = "P21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear",
abstract = "Objective-Rho GTPase proteins play a central role in regulating the dynamics of the platelet actin cytoskeleton. Yet, little is known regarding how Rho GTPase activation coordinates platelet activation and function. In this study, we aimed to characterize the role of the Rho GTPase effector, p21 activated kinase (PAK), in platelet activation, lamellipodia formation, and aggregate formation under shear. Approach and Results-Stimulation of platelets with the glycoprotein receptor VI agonist, collagen-related peptide, rapidly activated PAK in a time course preceding phosphorylation of PAK substrates, LIM domain kinase LIMK1 and the MAPK/ERK kinase MEK, and the subsequent activation of MAPKs and Akt. Pharmacological inhibitors of PAK blocked signaling events downstream of PAK and prevented platelet secretion as well as platelet aggregation in response to collagen-related peptide. PAK inhibitors also prevented PAK activation and platelet spreading on collagen surfaces. PAK was also required for the formation of platelet aggregates and to maintain aggregate stability under physiological shear flow conditions. Conclusions-These results suggest that PAK serves as an orchestrator of platelet functional responses after activation downstream of the platelet collagen receptor, glycoprotein receptor VI.",
keywords = "Cell signaling, Platelet, Signal transduction",
author = "Joseph Aslan and Asako Itakura and Kristina Haley and Tormoen, {Garth W.} and Loren, {Cassandra P.} and Baker, {Sandra M.} and Jiaqing Pang and Jonathan Chernoff and Owen McCarty",
year = "2013",
month = "7",
doi = "10.1161/ATVBAHA.112.301165",
language = "English (US)",
volume = "33",
pages = "1544--1551",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - P21 activated kinase signaling coordinates glycoprotein receptor VI-mediated platelet aggregation, lamellipodia formation, and aggregate stability under shear

AU - Aslan, Joseph

AU - Itakura, Asako

AU - Haley, Kristina

AU - Tormoen, Garth W.

AU - Loren, Cassandra P.

AU - Baker, Sandra M.

AU - Pang, Jiaqing

AU - Chernoff, Jonathan

AU - McCarty, Owen

PY - 2013/7

Y1 - 2013/7

N2 - Objective-Rho GTPase proteins play a central role in regulating the dynamics of the platelet actin cytoskeleton. Yet, little is known regarding how Rho GTPase activation coordinates platelet activation and function. In this study, we aimed to characterize the role of the Rho GTPase effector, p21 activated kinase (PAK), in platelet activation, lamellipodia formation, and aggregate formation under shear. Approach and Results-Stimulation of platelets with the glycoprotein receptor VI agonist, collagen-related peptide, rapidly activated PAK in a time course preceding phosphorylation of PAK substrates, LIM domain kinase LIMK1 and the MAPK/ERK kinase MEK, and the subsequent activation of MAPKs and Akt. Pharmacological inhibitors of PAK blocked signaling events downstream of PAK and prevented platelet secretion as well as platelet aggregation in response to collagen-related peptide. PAK inhibitors also prevented PAK activation and platelet spreading on collagen surfaces. PAK was also required for the formation of platelet aggregates and to maintain aggregate stability under physiological shear flow conditions. Conclusions-These results suggest that PAK serves as an orchestrator of platelet functional responses after activation downstream of the platelet collagen receptor, glycoprotein receptor VI.

AB - Objective-Rho GTPase proteins play a central role in regulating the dynamics of the platelet actin cytoskeleton. Yet, little is known regarding how Rho GTPase activation coordinates platelet activation and function. In this study, we aimed to characterize the role of the Rho GTPase effector, p21 activated kinase (PAK), in platelet activation, lamellipodia formation, and aggregate formation under shear. Approach and Results-Stimulation of platelets with the glycoprotein receptor VI agonist, collagen-related peptide, rapidly activated PAK in a time course preceding phosphorylation of PAK substrates, LIM domain kinase LIMK1 and the MAPK/ERK kinase MEK, and the subsequent activation of MAPKs and Akt. Pharmacological inhibitors of PAK blocked signaling events downstream of PAK and prevented platelet secretion as well as platelet aggregation in response to collagen-related peptide. PAK inhibitors also prevented PAK activation and platelet spreading on collagen surfaces. PAK was also required for the formation of platelet aggregates and to maintain aggregate stability under physiological shear flow conditions. Conclusions-These results suggest that PAK serves as an orchestrator of platelet functional responses after activation downstream of the platelet collagen receptor, glycoprotein receptor VI.

KW - Cell signaling

KW - Platelet

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=84879079136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879079136&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.112.301165

DO - 10.1161/ATVBAHA.112.301165

M3 - Article

C2 - 23640496

AN - SCOPUS:84879079136

VL - 33

SP - 1544

EP - 1551

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 7

ER -